<p>A. Dose-response of Withanolide A showing growth-stimulatory effects in terms of % viability. B. MTT assay showing the inhibition of cell viability by β-Amyloid<sub>1-42</sub> and its reversal by Withanolide A at two concentrations on SK-N-MC cells. The values were expressed as percentage of cell viability compared to control cells and are the mean ± SD of four experiments. *** and ** indicates a statistically significant difference (p<0.0001) and (p<0.0018) respectively compared to controls. WA – Withanolide A; β-AMY - β-Amyloid<sub>1-42</sub></p
<p><b>Panels A and B</b>: Dose-responsive (0, 10 µM, 20 µM, 30 µM) treatment of SH-SY5Y cells for 48...
In spite of recent therapeutic advances, multiple myeloma (MM) remains a malignancy with very low cu...
<p>(A) Cells were treated with the indicated concentrations of WA, HW, AA, and geldanamycin (GM) for...
<p>(A) MDA-MB-231 cells were treated with the indicated concentrations of various withanolide compou...
<p>(A) Cortical neurons, BSMC, hepatocytes and dermal fibroblasts were treated with 10 µM fAβ (25–35...
<p>MTT assay showing the inhibition of % cell viability in HIV-1<sub>Ba-L</sub> (clade B), Cocaine a...
<p>A. Dose-response curve of Ashwagandha showing optimal concentrations and B. Dose-response cytotox...
<p>(A) Withanolides induce IKK degradation and inhibit NF-κB activation. MDA-MB-231 cells were treat...
<p>(A) Withanolides reduce the viability of MCF-7 cells. MCF-7 cells were treated with the indicated...
<p>(A) Morphology of the human normal (TIG) and cancer (U2OS) cells treated with different concentra...
The in vitro antiproliferative activity of a series of 22 naturally occurring withanolides was exami...
Status epilepticus (SE) is a medical emergency with high mortality and a risk factor for the develop...
<p>(A) Cells were treated with the indicated concentrations of various withanolide compounds for 12 ...
<p>(<b>A</b>) The effects of SS (3000 µg/ml), AT (1000 µg/ml), PRP (1000 µg/ml) or RP (1000 µg/ml) o...
<p>(A) Screening of 160 compounds for their potential to increase the number of human motor neurons ...
<p><b>Panels A and B</b>: Dose-responsive (0, 10 µM, 20 µM, 30 µM) treatment of SH-SY5Y cells for 48...
In spite of recent therapeutic advances, multiple myeloma (MM) remains a malignancy with very low cu...
<p>(A) Cells were treated with the indicated concentrations of WA, HW, AA, and geldanamycin (GM) for...
<p>(A) MDA-MB-231 cells were treated with the indicated concentrations of various withanolide compou...
<p>(A) Cortical neurons, BSMC, hepatocytes and dermal fibroblasts were treated with 10 µM fAβ (25–35...
<p>MTT assay showing the inhibition of % cell viability in HIV-1<sub>Ba-L</sub> (clade B), Cocaine a...
<p>A. Dose-response curve of Ashwagandha showing optimal concentrations and B. Dose-response cytotox...
<p>(A) Withanolides induce IKK degradation and inhibit NF-κB activation. MDA-MB-231 cells were treat...
<p>(A) Withanolides reduce the viability of MCF-7 cells. MCF-7 cells were treated with the indicated...
<p>(A) Morphology of the human normal (TIG) and cancer (U2OS) cells treated with different concentra...
The in vitro antiproliferative activity of a series of 22 naturally occurring withanolides was exami...
Status epilepticus (SE) is a medical emergency with high mortality and a risk factor for the develop...
<p>(A) Cells were treated with the indicated concentrations of various withanolide compounds for 12 ...
<p>(<b>A</b>) The effects of SS (3000 µg/ml), AT (1000 µg/ml), PRP (1000 µg/ml) or RP (1000 µg/ml) o...
<p>(A) Screening of 160 compounds for their potential to increase the number of human motor neurons ...
<p><b>Panels A and B</b>: Dose-responsive (0, 10 µM, 20 µM, 30 µM) treatment of SH-SY5Y cells for 48...
In spite of recent therapeutic advances, multiple myeloma (MM) remains a malignancy with very low cu...
<p>(A) Cells were treated with the indicated concentrations of WA, HW, AA, and geldanamycin (GM) for...